메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Bestqool Honors Workers With Light-Based Recovery Solutions This Labor Day

From Aug 27 through Sep 4, all Bestqool Products will be available at unbeatable prices. NEW YORK, Aug. 27, 2025 -- After long hours of daily work, the body needs more than rest — it requires a sustainable, gentle, and easy-to-maintain recovery method. Bestqool, a health and wellness technology brand for light-based recovery, is celebrating this year's Labor Day with an important message: Honor your labor by protecting the body that does the work. For a limited time, Bestqool is offering 12% off all products from August 27th to September 4th, giving workers the opportun
- 김갑성 기자
- 2025-08-27 23:31
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand

HONG KONG, Aug. 27, 2025 -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported a profitable first half of 2025, supported by an expanding user base, higher operating efficiency, and accelerated deployment of AI across its healthcare services and internal operations. Net Profit Swings to Positive as Targeted User Base Unlocks Growth Fangzhou posted revenue of RMB 1.494 billion for the six months ended June 30, up 12.9% from a year earlier. Net profit reached RMB 12.5 mill
- 김갑성 기자
- 2025-08-27 23:09
Harbour BioMed Reports 2025 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 27, 2025 -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its interim results for the six months ended June 30, 2025. Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed, commented: "In the first half of 2025, Harbour BioMed achieved several significant milestones. During the reporting period, the company's pro
- 김갑성 기자
- 2025-08-27 22:40
XtalPi Holdings Announces 2025 Interim Results

SHENZHEN, China, Aug. 27, 2025 -- Key Highlights from the Financial Report: Revenue surged 404% year over year to RMB 517 million in the first half of 2025. Adjusted net profit reached RMB 141 million, marking the company's first-ever half-year profitability. XtalPi was added to the MSCI China Small Cap Index, underscoring strong recognition of its investment value by the international capital markets. Significant breakthroughs and milestones were achieved across multiple business lines. Drug Discovery Solutions: The Deep Integration of Ad
- 김갑성 기자
- 2025-08-27 22:26
XtalPi Holdings Announces 2025 Interim Results

SHENZHEN, China, Aug. 27, 2025 -- Key Highlights from the Financial Report: Revenue surged 404% year over year to RMB 517 million in the first half of 2025. Adjusted net profit reached RMB 141 million, marking the company's first-ever half-year profitability. XtalPi was added to the MSCI China Small Cap Index, underscoring strong recognition of its investment value by the international capital markets. Significant breakthroughs and milestones were achieved across multiple business lines. Drug Discovery Solutions: The Deep Integration of Ad
- 황정호 기자
- 2025-08-27 22:23
Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0

Start Your Journey to Access Vast Chemical Space CHENGDU, China, Aug. 27, 2025 -- Developing new medicines demands smart technology and powerful tools. DNA-encoded library (DEL) technology, with its unique ability to rapidly screen billions of compounds to identify small molecule hits, has transformed drug discovery. HitGen Inc. is raising the bar with the introduction of OpenDEL™ 5.0 – featuring a total of 4 billion diverse compounds designed to tackle challenging biological targets. OpenDEL™ 5.0 comes in a convenient kit format that is accessible to scientists in industry and
- 김갑성 기자
- 2025-08-27 21:30
Neusoft Medical Systems Launches China's First Photon-Counting CT with NMPA Approval

SHENYANG, China, Aug. 27, 2025 -- Neusoft Medical Systems today announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Products Administration (NMPA). This marks the first photon‑counting CT approved in China, and the world's first wide‑body system equipped with an 8‑cm detector. Photon-counting CT (PCCT) is considered a breakthrough in next‑generation imaging. Unlike conventional CT scanners, which first convert X‑rays into light before generating digital images, the NeuViz P10 uses a cadmium zinc telluride (CZT) detector t
- 김갑성 기자
- 2025-08-27 21:03
NUHS SPEARHEADS AI-POWERED BRAIN CARE PROGRAMME TO TACKLE UNDERDIAGNOSIS AND IMPROVE PREVENTION OF DEMENTIA

Novel initiative in Asia integrates predictive AI with personalised health coaching to empower early action and prevention SINGAPORE, Aug. 27, 2025 -- Dementia remains a hidden epidemic in Singapore, with slightly more than half of all cases going undiagnosed. According to the Well-being of the Singapore Elderly (WiSE) 2023[1] study, 51.5 per cent of dementia cases remain undetected. This is a troubling figure given that an estimated 45 per cent of dementia cases are preventable through early lifestyle interventions[2]. In an effort to close this gap, a multidisc
- 김갑성 기자
- 2025-08-27 21:00
NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia's earnings

NEW YORK, Aug. 27, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia’s earnings Ashley Mastronardi delivers the pre-market update on August 27th Equities are up this morning as investors wait for chip giant Nvidia's Q2 earnings report. The company is set to release the earnings after market close this afternoon. As the most heavily weig
- 황정호 기자
- 2025-08-27 20:55
Fosun International: Total Revenue for the First Half of 2025 Reaches RMB87.28 Billion, Industrial Operation Profit Amounts to RMB3.15 Billion

HONG KONG, Aug. 27, 2025 -- On 27 August, Fosun International Limited (HKEX stock code: 00656) announced its interim results for the six months ended 30 June 2025. In the first half of 2025, Fosun actively captured macroeconomic trends, maintained a clear strategic focus, and leveraged its strong capabilities in innovation and globalization to drive steady business development. During the Reporting Period, the Group's total revenue reached RMB87.28 billion, industrial operation profit amounted to RMB3.15 billion, and profit attributable to owners of the parent reached RMB661.2 million.
- 황정호 기자
- 2025-08-27 20:40

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-09-04_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 04일 12시 20분